While Vafseo is now approved in 37 countries, the FDA did give the oral prolyl hydroxylase inhibitor a boxed warning over a heightened risk of death, stroke, myocardial infection, venous thromboembolism and thrombosis of vascular access
To enhance safety, existing guidance includes subcutaneous-only injections, limiting graft volume per session, experienced surgeons, ultrasound guidance in certain practices, and scrupulous patient selection
The most common ones are gastrointestinal which makes sense, since these drugs work partly in the gut
The peptides selectivity may reduce unwanted observations, making it a compound of interest in studies exploring the modulation of growth hormone pathway
The rapid growth of the global overweight and diabetes population has given birth to the 100 billion market of GLP-1 drugs, and has also pushed its upstream API industry into a golden age